Endoscopic Ultrasound Needles Market Outlook:
Endoscopic Ultrasound Needles Market size was over USD 320.4 million in 2025 and is estimated to reach USD 780.5 million by the end of 2035, exhibiting a CAGR of 7.2% during the forecast period, i.e., 2026-2035. In 2026, the industry size of endoscopic ultrasound needles is estimated at USD 348.4 million.
Growth in the market is an evident result of the growing patient pool of gastrointestinal and oncological conditions requiring minimally invasive diagnostic and therapeutic procedures. Testifying to this demography, the World Health Organization (WHO) report predicted the counts of incidence and deaths due to cancer worldwide to surpass 16.3 million and 30.2 million, respectively, by 2040. On the other hand, the International Agency for Research on Cancer (IARC) calculated the same figures to be 10 million and 20 million in 2022, which indicates the continuous rise in the epidemiology. Besides, the rapidly aging populations that are highly prone to developing associated ailments are pushing authorities to reinforce adequate diagnostic infrastructure to enable early prevention.
As the burden of these medical illnesses grows, the scale and volume of financial exhaustion become more evident, which can be optimized through timely detection and intervention. Thus, the trend of early-stage diagnosis is propelling demand in the market. However, despite the cost-effectiveness of these procedures, continuous inflation in raw material costs, strict quality control, and supply chain disruptions collectively impact the economic liberty of both manufacturers and service providers. This ultimately translates to a higher payer’s pricing of services, which limits adoption in underserved regions, particularly in low- and middle-income countries (LMICs).
